Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Vitamin D × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 5 Prostatic Neoplasms 3 Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Bone Diseases, Metabolic 2 Stomach Neoplasms 1 Psychological Well-Being 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Melanoma, Cutaneous Malignant 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Fractures, Bone 1 Esophageal Neoplasms 1 Disease Progression 1 Cardiovascular Diseases 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 7 Prednisone 7 Drug Therapy 7 Doxorubicin 7 Anastrozole 7 Rituximab 6 Ondansetron 6 Morphine 6 Irinotecan 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01646437 2021-09-16

TIPS-3

Population Health Research Institute

Phase 3 Completed

Cardiovascular Diseases, Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡